Todas as matérias desta categoria, das mais recentes às mais antigas.
ADC Therapeutics (NYSE:ADCT), a commercial-stage biotechnology company specializing in antibody-drug conjugates (ADCs), reported its financial results for the first quarter of 2026.
Neurocrine Biosciences (NASDAQ:NBIX) officially entered the clinical arena for metabolic disorders today, announcing the initiation of a Phase 1 first-in-human study for NBIP-'2118.
Tyson Foods (NYSE:TSN) reported its second-quarter 2026 financial results, characterized by a significant rebound in GAAP profitability and steady top-line growth.
L.B. Foster Company (NASDAQ:FSTR) reported a robust first quarter for 2026, highlighted by a 23.9% year-over-year increase in net sales to $121.1 million.
RLJ Lodging Trust (NYSE:RLJ) delivered a solid start to 2026, reporting first-quarter results that outpaced the prior year across several key performance metrics.
DiamondRock Hospitality Company (NYSE:DRH) announced today the sale of its leasehold interest in the 189-room Courtyard by Marriott New York Manhattan/Fifth Avenue for $33 million.
Global Business Travel Group (NYSE:GBTG), operating as American Express Global Business Travel (Amex GBT), reported a 35% increase in first-quarter 2026 revenue to $840 million.
The Marzetti Company (NASDAQ:MZTI) reported financial results for its fiscal third quarter ended March 31, 2026, characterized by record gross margins and significant strategic investment.
Superior Group of Companies (NASDAQ:SGC) reported a return to profitability for the first quarter of 2026, marking a significant operational turnaround from a year ago.
Axsome Therapeutics (NASDAQ:AXSM) reported a 57% year-over-year increase in net product revenue for the first quarter of 2026, totaling $191.2 million.
Pulse Biosciences (NASDAQ:PLSE) reported its financial results for the first quarter of 2026, marking a pivotal transition from a pure-research entity to early-stage commercialization of its proprietary nPulse™ technology.
NAPCO Security Technologies (NASDAQ:NSSC) reported a robust 11.8% increase in net revenue for its third fiscal quarter of 2026, reaching $49.2 million.
